Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
about
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsComparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosisThe history of neuromyelitis opticaWhat do we know about brain contrast enhancement patterns in neuromyelitis optica?Aquaporin-4 autoimmunityUpdate on biomarkers in neuromyelitis opticaInternational consensus diagnostic criteria for neuromyelitis optica spectrum disordersAtypical presentations of neuromyelitis opticaPhysiological roles of aquaporin-4 in brainImmunology of neuromyelitis optica: a T cell-B cell collaborationMolecular pathogenesis of neuromyelitis opticaConventional and advanced imaging in neuromyelitis opticaUse of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum DisorderMRI characteristics of neuromyelitis optica spectrum disorder: an international updateNeuromyelitis optica lesions may inform multiple sclerosis heterogeneity debateThe immunopathology of multiple sclerosis: an overviewAberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body EcologyDifferential diagnosis of suspected multiple sclerosis: a consensus approachHeadache in Neuromyelitis Optica.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeMolecular disruptions of the panglial syncytium block potassium siphoning and axonal saltatory conduction: pertinence to neuromyelitis optica and other demyelinating diseases of the central nervous system.The expanded spectrum of neuromyelitis optica: evidences for a new definition.Sleep abnormality in neuromyelitis optica spectrum disorder.Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Magnetic resonance imaging in neuromyelitis optica.Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.Altered topological organization of white matter structural networks in patients with neuromyelitis optica.Devic's neuromyelitis optica: a critical review.Neuromyelitis optica in Brazil: a study on clinical and prognostic factors.Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab statusHydrocephalus in neuromyelitis optica.Recurrent Longitudinally Extensive Myelitis and Aquaporin-4 Seronegativity - The Expanding Spectrum of Neuromyelitis Optica.Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis opticaDifferential diagnosis of neuromyelitis optica spectrum disorders.Hypocretin/orexin and narcolepsy: new basic and clinical insights.Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorder.Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumab
P2860
Q21093230-F534C04E-5861-4D70-8C32-F037C27EA02BQ21135278-23871083-7488-4082-ACBA-968F37864D5DQ21245248-C4A73F27-478F-4ABE-A16E-29EB85578CD3Q26776278-819A050D-8106-4F13-8204-A59F5B60778BQ26799559-BDFED09B-47D0-45CC-B2D5-D1A813B1139DQ26799789-5713E159-6BF7-47D7-854D-588B0C0D9FF4Q26824579-70394D8A-0D50-4F5A-B41F-43C75608A7BCQ26827156-AAC63AE4-45EB-40B8-B032-52BA074EF595Q26866009-52A8EF90-311E-4B32-A208-EF0CA8DDAE04Q27016045-06865985-D68D-41E6-8C38-0BBC7F44F58DQ27021535-69BEAE75-1D27-4B53-9EF8-3FAE27652CF1Q27021822-2BDF03CE-F5C0-43B8-AF1C-6E8267DF7EEFQ28085378-12D1A648-8F39-4BE4-9CB1-2946FAA28383Q28087067-DB6CA7C7-E129-4B03-9590-2FF458CA9F1AQ28276365-49DE9EDA-9991-478A-BBDC-56546C2AE8D6Q28295115-DA8426BA-7932-4721-8CC1-42C2ECB76DD1Q28299160-5FBF7772-6374-4AAA-A675-074F0DE62F91Q29039412-4039A24E-00DD-465B-8040-3D58DEE8A781Q30235347-D3531606-5200-4BB1-9E9F-5AE076607464Q30371412-A4163782-2DEB-4CD9-8B2E-80F0AA4E92EEQ30474717-F2966994-AADF-483B-B778-A064277DDB9BQ30573084-DD9CB823-FB10-4EE1-A9AB-DD3418B5BAA3Q30642348-3C494301-4F6B-4E60-B5D6-622A4D981F3FQ30676331-C5365221-56FA-401E-A013-B5C2E4B489DCQ30785267-C6AE6E20-36DC-4CB4-BAAF-C8634C195090Q30820823-E2BE943C-E566-4C9C-A6B6-9A9371DBDA97Q30833332-9DF2FDA5-01AC-40CB-AA9C-A63BF2BA10C3Q30975717-15DD8DE1-9C24-4CCF-9F02-B85D3E015190Q31106733-ED3194F6-5768-4A4D-A623-035B7A640375Q31151651-35DB33F0-1B0E-4218-BA12-C011CCE722CEQ33419781-E18E6D89-7357-4B2B-9887-691CE96CF24EQ33646430-7E482A2A-74AF-450E-B52A-939F0F59CCF8Q33672598-20C3AFD4-3164-43B9-A814-C48DFCBDE0C1Q33741772-E2C5D1D4-2EBD-46BF-8018-49745E9FC602Q33802616-943E0FBB-AB5D-4DD1-B9B7-AFDA3036534BQ33812063-EA0996B7-ABF6-4806-ADC9-B92D478510C6Q33814590-945540A3-3D48-4456-898E-6A66A9CB216FQ33889721-EB826F06-4BFF-454E-91AF-BCD80DE1B65DQ33892764-CE623E7D-3BE0-4D44-BFEA-84DA02058FDBQ33895664-1161C21E-59D4-401B-9FD8-B72C3EECFFF9
P2860
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
@ast
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
@en
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
@nl
type
label
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
@ast
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
@en
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
@nl
prefLabel
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
@ast
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
@en
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
@nl
P2093
P1433
P1476
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
@en
P2093
Brian G Weinshenker
Claudia F Lucchinetti
Dean M Wingerchuk
John R Corboy
Sean J Pittock
Vanda A Lennon
P304
P356
10.1001/ARCHNEUR.63.7.964
P577
2006-07-01T00:00:00Z